Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Time to second biochemical recurrence as a prognostic indicator in postprostatectomy patients who undergo salvage radiation therapy: An RTOG 9601 based post hoc analysis.
Brodowsky EC, Sood A, Butaney M, Majdalany SE, Stephens A, Corsi N, Piontkowski AJ, Rakic I, Jamil M, Dalela D, Peabody JO, Rogers CG, Abdollah F. Brodowsky EC, et al. Among authors: rogers cg. Prostate. 2022 Sep 19. doi: 10.1002/pros.24436. Online ahead of print. Prostate. 2022. PMID: 36120850
Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis.
Corsi NJ, Messing EM, Sood A, Keeley J, Bronkema C, Rakic N, Jamil M, Dalela D, Arora S, Piontkowski AJ, Majdalany SE, Butaney M, Rakic I, Li P, Menon M, Rogers CG, Abdollah F. Corsi NJ, et al. Among authors: rogers cg. Clin Genitourin Cancer. 2022 Dec;20(6):e498-e505. doi: 10.1016/j.clgc.2022.06.015. Epub 2022 Jun 25. Clin Genitourin Cancer. 2022. PMID: 35871040
Optimizing anti-androgen treatment use among men with pathologic lymph-node positive prostate cancer treated with radical prostatectomy: the importance of postoperative PSA kinetics.
Sood A, Zhang LT, Keeley J, Butaney M, Stricker M, Andrews JR, Grauer R, Peabody JO, Rogers CG, Menon M, Abdollah F. Sood A, et al. Among authors: rogers cg. Prostate Cancer Prostatic Dis. 2022 Jul 6. doi: 10.1038/s41391-022-00572-z. Online ahead of print. Prostate Cancer Prostatic Dis. 2022. PMID: 35794359
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis.
Modonutti D, Majdalany SE, Corsi N, Li P, Sood A, Dalela D, Jamil ML, Hwang C, Menon M, Rogers CG, Trinh QD, Novara G, Abdollah F. Modonutti D, et al. Among authors: rogers cg. Prostate. 2022 Sep;82(13):1293-1303. doi: 10.1002/pros.24403. Epub 2022 Jul 5. Prostate. 2022. PMID: 35790016
Anti-Androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy: A Post Hoc Analysis of the RTOG-9601 Trial Data.
Sood A, Keeley J, Palma-Zamora I, Chien M, Corsi N, Jeong W, Rogers CG, Trinh QD, Peabody JO, Menon M, Abdollah F. Sood A, et al. Among authors: rogers cg. Ann Surg Oncol. 2022 Oct;29(11):7206-7215. doi: 10.1245/s10434-022-11892-8. Epub 2022 May 24. Ann Surg Oncol. 2022. PMID: 35608801 Free PMC article.
John Kelso Ormond - More Than a Syndrome.
Kachroo N, Rogers CG, Peabody JO. Kachroo N, et al. Among authors: rogers cg. Urology. 2022 Mar 31:S0090-4295(22)00171-6. doi: 10.1016/j.urology.2022.02.017. Online ahead of print. Urology. 2022. PMID: 35369985 No abstract available.
196 results